0 NASDAQ Companies - March 31, 2020Arvinas to Present at the American Society of Clinical Oncology Annual MeetingNEW HAVEN, Conn., March 31, 2020 (GLOBE NEWSWIRE) — Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new […]Read More
0 NASDAQ Companies - March 31, 2020Prevail Therapeutics to Present at AAT-AD/PD Focus Meeting 2020: Advances in Alzheimer’s and Parkinson’s TherapiesDesign of PROPEL Phase 1/2 Clinical Trial for Parkinson’s Disease Patients with GBA1 Mutations to Be PresentedPreclinical Data of PR001 […]Read More
0 NASDAQ Companies - March 31, 2020Amarin Highlights VASCEPA® (Icosapent Ethyl)-Related Data Presented at American College of Cardiology’s Annual Scientific Session Together With World Congress of Cardiology (ACC.20/WCC)DUBLIN, Ireland and BRIDGEWATER, N.J., March 31, 2020 (GLOBE NEWSWIRE) — Amarin Corporation plc (NASDAQ:AMRN), hosted a webcast yesterday to […]Read More
0 NASDAQ Companies - March 31, 2020GW Pharmaceuticals and Greenwich Biosciences Announce FDA Acceptance of sNDA Filing with Priority Review for EPIDIOLEX® (cannabidiol) in the Treatment of Seizures Associated with Tuberous Sclerosis ComplexCARLSBAD, Calif., March 31, 2020 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (Nasdaq: GWPH), the world leader in the science, development, […]Read More
0 NASDAQ Companies - March 31, 2020I-Mab Announces Financial Results for the Full Year Ended December 31, 2019, and Provides Corporate UpdateSuccessfully completed initial public offering raising approximately $114.5 million in gross proceedsContinued execution across broad pipeline portfolio; multiple clinical data […]Read More
0 NASDAQ Companies - March 31, 2020Anavex Life Sciences Provides Update on Clinical Program Development as Response to COVID-19NEW YORK, March 31, 2020 (GLOBE NEWSWIRE) — Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage […]Read More
0 NASDAQ Companies - March 31, 2020BioNTech Announces Full Year 2019 Financial Results and Corporate UpdateBNT111 FixVac Melanoma registrational trial start planned for 2H 2020BNT121 (iNeST) adjuvant Phase 2 study in NSCLC to start in […]Read More
0 NASDAQ Companies - March 31, 2020ZoneAlarm Launches New Web Secure Free Advanced Chrome Extension to Protect Users against the Most Common Online ThreatsSAN CARLOS, Calif., March 31, 2020 (GLOBE NEWSWIRE) — Check Point Software Technologies Ltd. (NASDAQ: CHKP) has today announced the […]Read More
0 NASDAQ Companies - March 31, 2020RADWARE SELECTED BY MAJOR BUSINESS INFORMATION PROVIDER TO SUPPORT INCREASED CAPACITY NEEDS FROM SWITCH TO REMOTE WORKMAHWAH, N.J., March 31, 2020 (GLOBE NEWSWIRE) — Radware® (NASDAQ: RDWR), a leading provider of cyber security and application delivery […]Read More
0 NASDAQ Companies - March 31, 2020ProQR Announces Positive Findings From an Interim Analysis in the Phase 1/2 trial of QR-421a for Usher Syndrome and Provides Business UpdateQR-421a showed early and encouraging evidence of activity, with 25% of patients showing a benefit across multiple concordant outcome measures […]Read More